ESMO Real-World Data and Digital Oncology: a journal to understand how health systems can help provide better cancer care Authors: Rodrigo Dienstmann Published: 2023 Real-world data (RWD) and digital health are a new field of science that will support many aspects of clinical practice. They are vehicles that can return value to society in an unprecedented manner in the form of generalizable observational research, population health management, learning healthcare systems, direct-to-patient mobile applications, among others. RWD can be the basis for many interrogations, such as describing underrepresented populations in clinical trials, reporting new phenomena and effectiveness of medical interventions in uncontrolled environments, exposing gaps in patient care, identifying accessibility issues of cancer drugs, supporting public policy and regulatory decisions. Similarly, digital tools can upgrade the practice of medicine with the development of technological solutions to monitor, process, and integrate different data at the individual and population levels to help address the problems faced by patients, clinicians, and health systems. Real-world data and digital oncology are interconnected research topics, entirely reliant on technical infrastructures for data collection, transformation, harmonization, qualification, and exploration. As a result, ESMO Real-World Data and Digital Oncology journal will set the stage for the transformation of medical oncology through the incorporation of scientific evidence derived from real-world sources and cross-fertilization of different domains with technology-enabled decision support systems (see Figure 1). We as the health community must tear down the current barrier between the structured clinical trial research setting and real-world routine care, and instead use data gathered in everyday practice to generate new knowledge.Figure 1Selection of Real-World Data and Digital Oncology use cases in different domains of interest for the target audience of the journal. Selection of Real-World Data and Digital Oncology use cases in different domains of interest for the target audience of the journal. Although the benefits of real-world evidence and digital revolutions are easy to point out, the magnitude of the challenges they create is hard to predict. Therefore, the ESMO Real-World Data and Digital Oncology journal will clarify misunderstandings around RWD as a reliable source of information, as well as the mistrust in the potential for clinical informatics solutions or artificial intelligence algorithms to support care delivery. Our mission is to up- and reskill the medical oncology community as we navigate this new field of science, providing guidance in the design and interpretation of RWD studies, or implementation of digital technologies in health ecosystems at all levels. It is true that oncologists often underestimate the value of RWD, partially because most studies report incomplete and siloed data, consequently unfit to addressing relevant scientific questions. The journal will promote the use of RWD reporting standards that help retrieving actionable evidence from real-world sources, such as the ESMO Guidance for Reporting Oncology real-World evidence (GROW)1. We will promote the adoption of guidelines and tools to assess data accuracy and to measure quality in order to deal with intrinsic biases and make RWD insights reliable and manageable: fit-for-purpose real-world evidence. With due diligence and proper statistical methodology, RWD analytics can be used to generate insights for clinical and operational pathways, offering the potential for short-term improvement in healthcare systems at the local and global levels. In addition, there is increasing interest in the use of RWD to support regulatory decision-making across the product life cycle, which is encouraging governments, institutions, and the industry to invest heavily in digital infrastructures to enable large interoperable observational studies. ESMO Real-World Data and Digital Oncology will excel in these scientific communications, building confidence in the community to make wise use of the evidence coming from the real-world. Furthermore, ESMO Real-World Data and Digital Oncology will be a reference journal for standardization of digital tools to foster greater accessibility and transferability, both across countries as well as sectors. It is expected that the new digital era of oncology will democratize access to care and empower patients to engage with their health in a preventive way. It also promises to help clinicians to deal with the increasing volume and complexity of patients’ data in a cost-efficient and time-saving manner. There are many examples of computational pathology and radiology tools in routine use for cancer diagnosis, but the development of algorithms for therapeutic decision-making in oncology is still in early phases. The journal will support organizational leaders as they engage with digital solutions to solve complex cancer problems by publishing studies that evaluate the net benefit of incorporating medical devices and artificial intelligence models in oncology practice, or that explore how the human aspect of medicine, i.e., interactions between patient and physician, may be affected by “machines”. ESMO Real-World Data and Digital Oncology content will be delivered using vocabulary that is understandable to oncologists, who need to be educated in the critical analysis of methods and endpoints employed in digital oncology studies. The journal will also promote adoption of governance mechanisms to safeguard privacy and trust, allowing meaningful and inclusive public-private collaborations and patient involvement in the digital health transformation. ESMO is mindful of the impact of technological disruption in healthcare systems, and the journal will therefore provide balanced implementation guidance, training, and resources to ensure appropriate use of real-world data, digital solutions, and artificial intelligence models, so that the transformation does not leave people behind or exacerbate health disparities. The ESMO Real-World Data and Digital Oncology journal will help deliver on these ambitions in a timely fashion by serving as the go-to journal for modern real-world and data science, transforming today’s obstacles into opportunities across borders.